InvestorsHub Logo

ziploc_1

06/30/22 8:54 AM

#381634 RE: HDGabor #381602

HDG...Without an IPO, Eddingpharm will have inadequate cash to pay for...
1. milestone payments
2. royalties
3. purchases of Vascepa shipments
4. marketing in China

Perhaps it is time for Amarin to look for another partner in China.